HerzSupplement - Pentalong von Actavis
HerzSupplement - Pentalong von Actavis
HerzSupplement - Pentalong von Actavis
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
Herz Supplement<br />
Cardiovascular Diseases<br />
4. Thum T. Bauersachs J. Microarray-based gene<br />
expression profiling to elucidate cellular responses<br />
to nitric oxide – a review from an analytical<br />
and biomedical point of view. J Chromatogr<br />
B Analyt Technol Biomed Life Sc 2007;<br />
851(1–2):3–11<br />
5. Pilz R.B. Casteel D.E. Regulation of gene expression<br />
by cyclic GMP. Circ Res 2003;93(11):1034–<br />
1046<br />
6. Dhakshinamoorthy S et al. Protein/DNA arrays<br />
identify nitric oxide-regulated cis-element and<br />
trans-factor activities some of which govern<br />
neuroblastoma cell viability. Nucleic Acids Res<br />
2007;35(16):5439–5451<br />
7. Akool el S et al. Nitric oxide increases the decay<br />
of matrix metalloproteinase 9 mRNA by inhibiting<br />
the expression of mRNA-stabilizing factor<br />
HuR. Mol Cell Biol 2003;23(14):4901–4916<br />
8. Kuwano Y et al. Analysis of nitric oxide-stabilized<br />
mRNAs in human fibroblasts reveals HuRdependent<br />
heme oxygenase 1 upregulation.<br />
Mol Cell Biol 2009;29(10):2622–2635<br />
9. Hentze MW, Kuhn LC. Molecular control of vertebrate<br />
iron metabolism: mRNA-based regulatory<br />
circuits operated by iron, nitric oxide, and<br />
oxidative stress. Proc Natl Acad Sci U S A 1996;<br />
93(16):8175–8182<br />
10. Zhou J et al. NO and TNF-alpha released from<br />
activated macrophages stabilize HIF-1alpha in<br />
resting tubular LLC-PK1 cells. Am J Physiol Cell<br />
Physiol 2003;284(2):C439–446<br />
11. Wang EQ et al. cDNA microarray analysis of vascular<br />
gene expression after nitric oxide donor<br />
infusions in rats: implications for nitrate tolerance<br />
mechanisms. AAPS PharmSci 2002; 4(2):<br />
E10<br />
12. Stalleicken D, Schröder H. In-vivo- und Humanstudien<br />
bestätigen das antioxidative und toleranzfreie<br />
Wirkprofil <strong>von</strong> PETN. Perfusion 2008;<br />
21:4–6<br />
13. Dhakshinamoorthy S, Porter AG. Nitric oxideinduced<br />
transcriptional up-regulation of protective<br />
genes by Nrf2 via the antioxidant response<br />
element counteracts apoptosis of neuroblastoma<br />
cells. J Biol Chem 2004;279(19):<br />
20096–20107<br />
14. Misquitta CM et al. The role of 3‘-untranslated<br />
region (3‘-UTR) mediated mRNA stability in cardiovascular<br />
pathophysiology. Mol Cell Biochem<br />
2001;224(1–2):53–67<br />
15. Khabar KS. The AU-rich transcriptome: more than<br />
interferons and cytokines, and its role in disease.<br />
J Interferon Cytokine Res 2005;25(1):1–10.<br />
16. Pautz A et al. Effects of nitroglycerin or pentaerithrityl<br />
tetranitrate treatment on the gene<br />
expression in rat hearts: evidence for cardiotoxic<br />
and cardioprotective effects. Physiol Genomics<br />
2009;38(2):176–185<br />
17. Clarke PA et al. Gene expression microarray analysis<br />
in cancer biology, pharmacology, and drug<br />
development: progress and potential. Biochem<br />
Pharmacol 2001;62(10):1311–1336<br />
18. Gupta S et al. Activation of nuclear factor-kappaB<br />
is necessary for myotrophin-induced cardiac<br />
hypertrophy. J Cell Biol 2002;159(6):1019–<br />
1028<br />
19. Wang J et al. Convergence of protein kinase<br />
C and JAK-STAT signaling on transcription factor<br />
GATA-4. Mol Cell Biol 2005;25(22):9829–<br />
9844.<br />
20. Thuerauf DJ et al. p38 Mitogen-activated protein<br />
kinase mediates the transcriptional induction<br />
of the atrial natriuretic factor gene through<br />
a serum response element. A potential role for<br />
the transcription factor ATF6. J Biol Chem 1998;<br />
273(32):20636–20643<br />
21. Xu J et al. Myocyte enhancer factors 2A and 2C<br />
induce dilated cardiomyopathy in transgenic<br />
mice. J Biol Chem 2006;281(14): 9152–9162<br />
22. Aerts S et al. TOUCAN 2: the all-inclusive open<br />
source workbench for regulatory sequence analysis.<br />
Nucleic Acids Res 2005;33(Web Server issue):W393–396<br />
23. Chekmenev DS et al. P-Match: transcription factor<br />
binding site search by combining patterns<br />
and weight matrices. Nucleic Acids Res 2005;<br />
33(Web Server issue):W432–437<br />
24. Nunez C et al. Discrepancies between nitroglycerin<br />
and NO-releasing drugs on mitochondrial<br />
oxygen consumption, vasoactivity,<br />
and the release of NO. Circ Res 2005; 97(10):<br />
1063–1069<br />
25. Kleschyov AL et al. Does nitric oxide mediate the<br />
vasodilator activity of nitroglycerin? Circ Res<br />
2003;93(9):e104–112<br />
26. Munzel T et al. Explaining the phenomenon<br />
of nitrate tolerance. Circ Res 2005;97(7):618–<br />
628<br />
27. Daiber A et al. Oxidative stress and mitochondrial<br />
aldehyde dehydrogenase activity: a comparison<br />
of pentaerythritol tetranitrate with other<br />
organic nitrates. Mol Pharmacol 2004; 66(6):<br />
1372–1382<br />
28. Janero DR et al. Differential nitros(yl)ation of<br />
blood and tissue constituents during glyceryl<br />
trinitrate biotransformation in vivo. Proc Natl<br />
Acad Sci U S A 2004;101(48):16958–16963<br />
29. Wenzel P et al. Number of nitrate groups determines<br />
reactivity and potency of organic nitrates:<br />
a proof of concept study in ALDH-2-/-<br />
mice. Br J Pharmacol 2007;150(4):526–533<br />
30. Gori T, Daiber A. Non-hemodynamic effects of<br />
organic nitrates and the distinctive characteristics<br />
of pentaerithrityl tetranitrate. Am J Cardiovasc<br />
Drugs, 2009;9(1):7–15<br />
31. Tassorelli C, Joseph SA. NADPH-diaphorase activity<br />
and Fos expression in brain nuclei following<br />
nitroglycerin administration. Brain Res 1995;<br />
695(1):37–44<br />
32. Tassorelli C et al. A role for brain cyclooxygenase-2<br />
and prostaglandin-E2 in migraine: effects<br />
of nitroglycerin. Int Rev Neurobiol 2007;82:373–<br />
382<br />
33. Greco R et al. Neuroprotective effect of nitroglycerin<br />
in a rodent model of ischemic stroke:<br />
evaluation of Bcl-2 expression. Int Rev Neurobiol<br />
2007;82:423–435<br />
34. Munzel T et al. Effects of long-term nitroglycerin<br />
treatment on endothelial nitric oxide synthase<br />
(NOS III) gene expression, NOS III-mediated superoxide<br />
production, and vascular NO bioavailability.<br />
Circ Res 2000;86(1):E7–E12<br />
35. Prevotat L et al. Nitric oxide-induced down-regulation<br />
of beta-catenin in colon cancer cells by<br />
a proteasome-independent specific pathway.<br />
Gastroenterology 2006;131(4):1142–1152<br />
36. Suwattanasophon C et al. 5-HT(1B/1D) serotonin<br />
receptor agonist attenuates nitroglycerin-evoked<br />
nitric oxide synthase expression in trigeminal<br />
pathway. Cephalalgia 2003;23(8):825–832<br />
37. Yamazaki A, Birnboim H.C. Potentiation of retinoic<br />
acid-induced U-937 differentiation into<br />
respiratory burst-competent cells by nitric oxide<br />
donors. Leuk Res 1995;19(5):325–335<br />
38. Otto A et al. Rosuvastatin treatment protects<br />
against nitrate-induced oxidative stress in<br />
eNOS knockout mice: implication of the<br />
NAD(P)H oxidase pathway. Br J Pharmacol 2006;<br />
148(4):544–552.<br />
39. Li J et al. Nitroglycerin protects small intestine<br />
from ischemia-reperfusion injury via NO-cGMP<br />
pathway and upregulation of alpha-CGRP. J<br />
Gastrointest Surg 2009;13(3):478–485<br />
40. Death AK et al. Nitroglycerin upregulates matrix<br />
metalloproteinase expression by human<br />
macrophages. J Am Coll Cardiol 2002;39(12):<br />
1943–1950.<br />
41. Szocs K et al. Increased superoxide production<br />
in nitrate tolerance is associated with NAD(P)H<br />
oxidase and aldehyde dehydrogenase 2 downregulation.<br />
J Mol Cell Cardiol 2007;42(6):1111–<br />
1118<br />
42. Pi X et al. Differential expression of genes from<br />
nitrate-tolerant rat aorta. J Vasc Res 2002; 39(4):<br />
304–310<br />
43. Oberle S et al. The antioxidant defense protein<br />
ferritin is a novel and specific target for pentaerithrityl<br />
tetranitrate in endothelial cells. Biochem<br />
Biophys Res Commun 1999;261(1):28–34<br />
44. Oberle S et al. Heme oxygenase-1 induction may<br />
explain the antioxidant profile of pentaerythrityl<br />
trinitrate. Biochem Biophys Res Commun<br />
2002;290(5):1539–1544<br />
45. Mollnau H et al. Mitochondrial oxidative stress<br />
and nitrate tolerance – comparison of nitroglycerin<br />
and pentaerithrityl tetranitrate in<br />
Mn-SOD+/- mice. BMC Cardiovasc Disord 2006;<br />
6:44.<br />
46. Dragoni S et al. Pentaerythrityl tetranitrate and<br />
nitroglycerin, but not isosorbide mononitrate,<br />
prevent endothelial dysfunction induced by ischemia<br />
and reperfusion. Arterioscler Thromb<br />
Vasc Biol 2007;27(9):1955–1959<br />
Für die Verfasser:<br />
Prof. Dr. Hartmut Kleinert<br />
Institut für Pharmakologie, Universitätsmedizin<br />
der Johannes Gutenberg-<br />
Universität, Obere Zahlbacher Str. 63<br />
55101 Mainz, Germany<br />
Tel.: +49 (0) 6131 17 9276<br />
Fax: +49 (0) 6131 17 9042<br />
66 Herz 35 · 2010 · Supplement II © Urban & Vogel